<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00573248</url>
  </required_header>
  <id_info>
    <org_study_id>2005-4296</org_study_id>
    <secondary_id>TRDRP grant# 14RT-0147H</secondary_id>
    <nct_id>NCT00573248</nct_id>
  </id_info>
  <brief_title>Nicotine and Behavior in Adult ADHD</brief_title>
  <official_title>Nicotine and Behavioral Regulation in Adult ADHD</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, Irvine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, Irvine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Attention deficit hyperactivity disorder (ADHD) is characterized by inattention, impulsivity,
      and hyperactivity that are frequently treated with stimulant medications such as Ritalin.
      Many people with ADHD smoke. The smoking prevalence rates are estimated to be 40% in adults
      with ADHD compared to 20% in the general population. People with ADHD have also more
      difficulty to quit smoking. Only 29% of smokers with ADHD quit smoking compared to 48.5% of
      smokers in the general population. Nicotine is a stimulant, which may have properties similar
      to stimulant medications (e.g., Ritalin) used to treat ADHD. Nicotine may increase attention
      and reduce hyperactivity and impulsivity and, thus, may regulate behavior in individuals with
      ADHD. Alleviating the symptoms of ADHD and increasing cardiovascular activity through smoking
      may mimic the effects of stimulant medications and can be a form of self-medication.

      The major objective of the study was to examine the effects of nicotine on ADHD symptoms,
      moods, and cardiovascular activity. The study investigated the effects of nicotine patches on
      behavioral regulation in adult smokers and nonsmokers with ADHD. Smokers and nonsmokers with
      ADHD participated in two conditions: (1) nicotine patch and (2) placebo patch. During each
      condition, symptoms, moods, and side effects were assessed for 2 days during waking hours. An
      electronic handheld diary, programmed to prompt the participant twice per hour, recorded ADHD
      symptoms (e.g., difficulty concentrating, impulsivity, etc.), negative moods (e.g., anger,
      stress), and nicotine side effects (nausea, dizziness). Heart rate and blood pressure were
      recorded with lightweight ambulatory monitors to indicate cardiovascular activity. Results
      provided information about the effects of nicotine patches on behavioral regulation in adult
      smokers and nonsmokers with ADHD.

      The inclusion of nonsmokers was important to clarify whether the effects of nicotine on
      smokers was due to smoking withdrawal. The findings help explain the increased smoking
      prevalence rates and reduced quit rates associated with ADHD. Knowledge about nicotine's
      effects on behavioral regulation can help to develop successful smoking cessation programs
      for individuals with ADHD. The findings on cardiovascular activity may help determine the
      potential risk for cardiovascular disease in smokers and nonsmokers with ADHD. The study
      contributed to understanding nicotine's effects on behavioral regulation in a highly
      vulnerable population such as people with ADHD.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2005</start_date>
  <completion_date type="Actual">December 2009</completion_date>
  <primary_completion_date type="Actual">December 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>ADHD Symptoms</measure>
    <time_frame>4 days</time_frame>
    <description>Mean percentage of endorsement for each electronic diary item (percent of 'yes' on an item) during 2 days on nicotine patches versus 2 days placebo patches</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Negative Moods</measure>
    <time_frame>4 days</time_frame>
    <description>Mean percentage of endorsement for each electronic diary item (percent of 'yes' on an item) during 2 days on nicotine patches versus 2 days placebo patches</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Side Effects</measure>
    <time_frame>4 days</time_frame>
    <description>Mean percentage of endorsement for each electronic diary item (percent of 'yes' on an item) during 2 days on nicotine patches versus 2 days placebo patches</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood Pressure</measure>
    <time_frame>4 days</time_frame>
    <description>Average blood pressure during 2 days on nicotine patches versus 2 days on placebo patches</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">78</enrollment>
  <condition>ADHD</condition>
  <arm_group>
    <arm_group_label>4</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nicotine</intervention_name>
    <description>21 mg nicotine patches for smokers for 2 days
7 mg nicotine patches for nonsmokers for 2 days</description>
    <arm_group_label>4</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo Patch</description>
    <arm_group_label>4</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  An age of 18 to 45 years

          -  A history of ADHD

          -  Current diagnosis of ADHD according to clinical criteria

          -  Being a smoker who smokes at least 10 cigarettes per day with 0.5 mg of nicotine per
             cigarette; OR

          -  Being a nonsmoker who has been abstaining from smoking and other nicotine products for
             the last 2 years

        Exclusion Criteria:

          -  Treatment for any chronic illness such as heart disease, irregular heartbeat, high
             blood pressure, diabetes, skin allergies or skin diseases, including psoriasis or
             eczema, even if currently controlled by medication

          -  Current pregnancy, as measured by a pregnancy test (Clear Blue Easy, Unipath, Bedford,
             UK), or planning to become pregnant within the next 6 months. These individuals will
             not be included as the nicotine patch may cause harm to the unborn fetus

          -  Nursing mothers, or women who have breastfed within the last 12 months

          -  Non-English speaking people, because the majority of measurements used in the study
             have not been validated in languages other than English

          -  Current major depressive episode according to clinical criteria

          -  Concurrent psychiatric psychoactive medication within the past 12 months

          -  Active substance abuse within the past 12 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean G Gehricke, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, Irvine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Pediatrics</name>
      <address>
        <city>Irvine</city>
        <state>California</state>
        <zip>92612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Gehricke JG, Hong N, Whalen CK, Steinhoff K, Wigal TL. Effects of transdermal nicotine on symptoms, moods, and cardiovascular activity in the everyday lives of smokers and nonsmokers with attention-deficit/hyperactivity disorder. Psychol Addict Behav. 2009 Dec;23(4):644-55. doi: 10.1037/a0017441.</citation>
    <PMID>20025370</PMID>
  </results_reference>
  <verification_date>September 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 12, 2007</study_first_submitted>
  <study_first_submitted_qc>December 13, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 14, 2007</study_first_posted>
  <results_first_submitted>April 1, 2011</results_first_submitted>
  <results_first_submitted_qc>August 2, 2011</results_first_submitted_qc>
  <results_first_posted type="Estimate">September 2, 2011</results_first_posted>
  <last_update_submitted>September 1, 2011</last_update_submitted>
  <last_update_submitted_qc>September 1, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 9, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Nicotine</keyword>
  <keyword>ADHD</keyword>
  <keyword>Gender</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nicotine</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Smokers</title>
          <description>In a modified within-group cross-over, smokers received 21 mg/day nicotine patches for two consecutive days and matching placebo patches for two consecutive days, with the order counterbalanced across participants.</description>
        </group>
        <group group_id="P2">
          <title>Nonsmokers</title>
          <description>In a modified within-group cross-over, nonsmokers received 7 mg/day nicotine patches for two consecutive days and matching placebo patches for two consecutive days, with the order counterbalanced across participants.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="40"/>
                <participants group_id="P2" count="38"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Nicotine Patches and Placebo Patches</title>
              <participants_list>
                <participants group_id="P1" count="25"/>
                <participants group_id="P2" count="27"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="25"/>
                <participants group_id="P2" count="27"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="11"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>scheduling conflicts</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="11"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Smokers</title>
          <description>In a modified within-group cross-over, smokers received 21 mg/day nicotine patches for two consecutive days and matching placebo patches for two consecutive days, with the order counterbalanced across participants.</description>
        </group>
        <group group_id="B2">
          <title>Nonsmokers</title>
          <description>In a modified within-group cross-over, nonsmokers received 7 mg/day nicotine patches for two consecutive days and matching placebo patches for two consecutive days, with the order counterbalanced across participants.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="40"/>
            <count group_id="B2" value="38"/>
            <count group_id="B3" value="78"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="40"/>
                    <measurement group_id="B2" value="38"/>
                    <measurement group_id="B3" value="78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25" spread="7"/>
                    <measurement group_id="B2" value="28" spread="8"/>
                    <measurement group_id="B3" value="27" spread="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="31"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="40"/>
                    <measurement group_id="B2" value="38"/>
                    <measurement group_id="B3" value="78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>ADHD Symptoms</title>
        <description>Mean percentage of endorsement for each electronic diary item (percent of 'yes' on an item) during 2 days on nicotine patches versus 2 days placebo patches</description>
        <time_frame>4 days</time_frame>
        <population>Per protocol, average ADHD symptoms, cardiovascular activity and moods during nicotine compared to placebo.</population>
        <group_list>
          <group group_id="O1">
            <title>Nicotine Patches</title>
            <description>Smokers received 21 mg/day patches for two consecutive days and nonsmokers received 7 mg/day nicotine patches for two consecutive days.</description>
          </group>
          <group group_id="O2">
            <title>Placebo Patches</title>
            <description>Smokers and nonsmokers received placebo patches for two consecutive days.</description>
          </group>
        </group_list>
        <measure>
          <title>ADHD Symptoms</title>
          <description>Mean percentage of endorsement for each electronic diary item (percent of 'yes' on an item) during 2 days on nicotine patches versus 2 days placebo patches</description>
          <population>Per protocol, average ADHD symptoms, cardiovascular activity and moods during nicotine compared to placebo.</population>
          <units>Percent of item endorsement</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="52"/>
                <count group_id="O2" value="52"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Difficulty concentrating</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="71.2" spread="4.0"/>
                    <measurement group_id="O2" value="78.4" spread="3.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Forgetfulness</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="47.4" spread="4.0"/>
                    <measurement group_id="O2" value="55.5" spread="4.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Restlessness</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="71.8" spread="3.9"/>
                    <measurement group_id="O2" value="78.5" spread="3.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Impatience</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="72.3" spread="4.2"/>
                    <measurement group_id="O2" value="79.4" spread="3.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Impulsivity</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="61.8" spread="4.7"/>
                    <measurement group_id="O2" value="71.5" spread="3.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>2 (nicotine versus placebo) x 2 (smokers versus nonsmokers) ANOVA for each diary item</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.025</p_value>
            <p_value_desc>Adjusted for multiple comparisons</p_value_desc>
            <method>ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Blood Pressure</title>
        <description>Average blood pressure during 2 days on nicotine patches versus 2 days on placebo patches</description>
        <time_frame>4 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Nicotine Patches</title>
            <description>Smokers received 21 mg/day patches for two consecutive days and nonsmokers received 7 mg/day nicotine patches for two consecutive days.</description>
          </group>
          <group group_id="O2">
            <title>Placebo Patches</title>
            <description>Smokers and nonsmokers received placebo patches for two consecutive days.</description>
          </group>
        </group_list>
        <measure>
          <title>Blood Pressure</title>
          <description>Average blood pressure during 2 days on nicotine patches versus 2 days on placebo patches</description>
          <units>mm HG</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="52"/>
                <count group_id="O2" value="52"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Systolic Blood Pressure</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="134" spread="17"/>
                    <measurement group_id="O2" value="131" spread="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Diastolic Blood Pressure</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="81" spread="11"/>
                    <measurement group_id="O2" value="78" spread="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>2 (nicotine versus placebo) x 2 (smoker versus nonsmoker) ANOVA</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.025</p_value>
            <method>ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Negative Moods</title>
        <description>Mean percentage of endorsement for each electronic diary item (percent of 'yes' on an item) during 2 days on nicotine patches versus 2 days placebo patches</description>
        <time_frame>4 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Nicotine Patches</title>
            <description>Smokers received 21 mg/day patches for two consecutive days and nonsmokers received 7 mg/day nicotine patches for two consecutive days.</description>
          </group>
          <group group_id="O2">
            <title>Placebo Patches</title>
            <description>Smokers and nonsmokers received placebo patches for two consecutive days.</description>
          </group>
        </group_list>
        <measure>
          <title>Negative Moods</title>
          <description>Mean percentage of endorsement for each electronic diary item (percent of 'yes' on an item) during 2 days on nicotine patches versus 2 days placebo patches</description>
          <units>Percent of item endorsement</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="52"/>
                <count group_id="O2" value="52"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Anger</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="60.0" spread="4.5"/>
                    <measurement group_id="O2" value="71.4" spread="4.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Nervousness</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="69.7" spread="4.1"/>
                    <measurement group_id="O2" value="77.1" spread="3.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Stress</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="66.9" spread="4.4"/>
                    <measurement group_id="O2" value="74.2" spread="3.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>2 (nicotine versus placebo) x 2 (smokers versus nonsmokers) ANOVA for each diary item</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.025</p_value>
            <p_value_desc>Adjusted for multiple comparisons</p_value_desc>
            <method>ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Side Effects</title>
        <description>Mean percentage of endorsement for each electronic diary item (percent of 'yes' on an item) during 2 days on nicotine patches versus 2 days placebo patches</description>
        <time_frame>4 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Nicotine Patches</title>
            <description>Smokers received 21 mg/day patches for two consecutive days and nonsmokers received 7 mg/day nicotine patches for two consecutive days.</description>
          </group>
          <group group_id="O2">
            <title>Placebo Patches</title>
            <description>Smokers and nonsmokers received placebo patches for two consecutive days.</description>
          </group>
        </group_list>
        <measure>
          <title>Side Effects</title>
          <description>Mean percentage of endorsement for each electronic diary item (percent of 'yes' on an item) during 2 days on nicotine patches versus 2 days placebo patches</description>
          <units>Percent of item endorsement</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="52"/>
                <count group_id="O2" value="52"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Nausea</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="37.7" spread="3.5"/>
                    <measurement group_id="O2" value="30.7" spread="3.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Dizziness</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33.5" spread="3.2"/>
                    <measurement group_id="O2" value="33.8" spread="3.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>2 (nicotine versus placebo) x 2 (smokers versus nonsmokers) ANOVA for each diary item</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.025</p_value>
            <p_value_desc>Adjusted for multiple comparisons</p_value_desc>
            <method>ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Smokers</title>
          <description>In a modified within-group cross-over, smokers received 21 mg/day nicotine patches for two consecutive days and matching placebo patches for two consecutive days, with the order counterbalanced across participants.</description>
        </group>
        <group group_id="E2">
          <title>Nonsmokers</title>
          <description>In a modified within-group cross-over, nonsmokers received 7 mg/day nicotine patches for two consecutive days and matching placebo patches for two consecutive days, with the order counterbalanced across participants.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="27"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>4</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="27"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Jean Gehricke, Ph.D.</name_or_title>
      <organization>University of California, Irvine</organization>
      <phone>949-824-1834</phone>
      <email>jgehrick@uci.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

